News and Comments

Biotechnology Companies: A Model that’s Gaining Visibility

  Tuesday, December 07, 2010

The biotechnology company model founded on management skills rather than purely on scientific skills has begun to gain investors’ appreciation. The reason is that many firms built around skilled, experienced entrepreneurs have succeeded in bringing a large number of drugs to the market and in marketing them competently. These firms license or acquire drugs in mid-or late-phase trials. They sometimes acquire therapeutic molecules in early-stage development only if these molecules prove to have optimal affinity on validated proteins in pathways of diseases, and produce desired agonist or antagonist effects. In order to select the products that can be called breakthroughs, the most successful of the firms established and run by entrepreneurs with strong business acumen employ specialists in pharmaceutical sciences and in clinical trials. These scientists have experience in sensitive areas such as drug development, clinical trials, medicinal chemistry, and other important disciplines required for drug discovery, development and testing.   More...

Recent Postings



Vertex (VRTX) Rapamune HALOZYME (HALO) ADVENTRIX (ANX) Sanofi-Aventis (SAN) Aimmune Therapeutics (AIMT) Elan (ELN) Cytokinetics (CYTK) Agenus (AGEN Dendreon (DNDN) Agenus (AGEN) Revlimid (lenolidamide) Roche (ROCHE) Ziofpharm (ZIOP) Onyx (ONXX) Trastuzumab-DM1 Array Pharmaceuticals (ARRY) Intercept (ICPT) Herceptin Galena (GALE) Amgen (AMGN) Alder Biopharmaceuticals (ALDR) ARGOS (ARGS) Inovio (INO) NEKTAR (NKTR)) Sarepta (SRPT) KERYX (KERX) CompuGen (CGEN) Global Cell Therapeutics (GBT) ACADIA (ACAD) OSI (OSIP) Incyte (INCY) Sanofi (SNY) Gilead (GILD) ABBVIE (ABBV) Multiple Myeloma KITE (KITE) REGULUS (RGLS) Abbott Laboratories (ABT) JUNO (JUNO) AGOS (ARGS) Velcade (bortezomib) Illumina (ILMN) AERIE PHARMACEUTICALS SUNESIS PHARMACEUTICALS (SNSS) GUARDIAN HEALTH Anadys (ANDS) INNOVIVA (INVA) Valeant Pharmaceuticals International (VRX) Prolor Biotech (PBTH) Ionis (IONS) Merck (MRK) Vitae Pharmaceuticals (VTAE) TOKAI (TKAOI) galapagos (GLPG) Anacor (ANAC) Human Longevity (HLI) BIOMARIN (BMRN) Auspex (ASPX) Intrexon (XON) Endometrial Cancer Tysabri ISIS (ISIS) Ocular Therapeutix (OCUL) Mirati Therapeutics (MRTX) Theravance Bio Pharma (TBPH) Micromet (MITI) MODERNA Regeneron (REGN) Exelixis (EXEL) Ariad (ARIA) CRISPR Therapeutics (CRSP) Biocryst (BCRX) Jazz Pharmaceuticals (JAZZ) Advaxis (ADXS) Bristol-Myers Squibb (BMY) Seattle Genetics (SGEN) Theravance (THRX) ARCA (ABIO) Intermune (ITMN) Benlysta (belimumab) VANDA (VNDA) AstraZeneca (AZN) Zerenex Biogen Idec (BIIB) ZALTRAP™ SERES THERAPEUTICS (MCRB) IDERA (IDRA) Roche (RHHBY) Sanofi (SNA) Ridaforolimus C4 Therapeutics RenenxBio (RGNX) Pluristem (PSTI) GlaxoSmithKline (GSK) ImmunoGen (IMGN) Sequenom (SQNM) Alnylam (ALNY) Dynavax (DVAX) Xoma (XOMA) NOVOCURE (NVCR) Spike Therapeutics (ONCE) SYNTA (SNTA) NANTKWEST (NK) Human Genome Sciences (HGSI) PTC Therapeutics (PTCT) Idenix (IDIX) Prosensa (RNA) Bellicum (BLCM) Adaptimmune (ADAP) Editas (EDIT) Telaprevir Genentech Sangamo (SGMO)